Stem cells and vascular dementia: from basic science to the clinic

被引:0
作者
Wenxia Jiang
Lei Gong
Fang Liu
Jun Mu
机构
[1] The First Affiliated Hospital of Chongqing Medical University,Department of Neurology
来源
Cell and Tissue Banking | 2020年 / 21卷
关键词
Stem cells; Vascular dementia; Transplantation; Neurogenesis; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Vascular dementia (VD) is the second most common cause of dementia following Alzheimer’s disease (AD). The major symptoms of VD including memory loss, language deficits and impairment of executive functions. Its specific etiology and pathogenesis remain unknown. Currently, treatment options of VD are still limited. The therapeutic strategies aim to control the vascular risk factors and improve the cognitive function. In recent years, cell therapy for neurodegenerative diseases has attracted a great deal of attention. Evidence suggested that stem cell transplantation could improve the symptoms of cerebral infarction and AD. Therefore, it may serve as a potential therapy for VD. We summarized the latest research results both in vitro and in vivo. Further, the clinical trial of stem cell transplantation in VD patients was also reviewed. Finally, the limitations and future directions of cell therapy in VD treatment were discussed.
引用
收藏
页码:349 / 360
页数:11
相关论文
共 161 条
  • [11] Min J(2017)Umbilical cord-derived mesenchymal stem cell transplantation for treating elderly vascular dementia Cell Tissue Bank 18 53-3625
  • [12] Goshgarian C(2018)Small vessels, dementia and chronic diseases—molecular mechanisms and pathophysiology Clin Sci (Lond) 132 851-25
  • [13] Fujita Y(2010)Transplanted bone marrow stromal cells improve cognitive dysfunction due to aging hypoperfusion in rats Chin Med J (Engl) 123 3620-372
  • [14] Ihara M(2017)Concise review: human embryonic stem cells-what have we done? What are we doing? Where are we going? Stem Cells 35 17-239
  • [15] Ushiki T(2016)Mesenchymal stem cell therapy for the streptozotocin-induced neurodegeneration in rats Neurol Res 38 364-102
  • [16] Gage FH(2018)The pathology and pathophysiology of vascular dementia Neuropharmacology 134 226-181
  • [17] Goodman RA(2016)Human brain microvascular endothelial cells derived from the BC1 iPS cell line exhibit a blood-brain barrier phenotype PLoS One 11 e0152105-201
  • [18] Lochner KA(2015)187 induced pluripotent stem cell (IPSC) model of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) Heart 101 105-866
  • [19] Thambisetty M(2015)Stereotactic brain injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer’s disease dementia: a phase 1 clinical trial Alzheimers Dement (NY) 1 95-271
  • [20] Guo D(2017)Synergistic effect of tanshinone IIA and mesenchymal stem cells on preventing learning and memory deficits via anti-apoptosis, attenuating tau phosphorylation and enhancing the activity of central cholinergic system in vascular dementia Neurosci Lett 637 175-791